Lymphoid Malignancies of Non-precursor Cells

[1]  Paulette Mehta,et al.  Wintrobe’s Clinical Hematology , 2009 .

[2]  W. Hiddemann,et al.  Proteome‐ and microarray‐based expression analysis of lymphoma cell lines identifies a p53‐centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma , 2007, Electrophoresis.

[3]  A. Ranki,et al.  Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL) , 2007, Cytogenetic and Genome Research.

[4]  L. Kenner,et al.  The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. , 2007, Blood.

[5]  N. Caporaso,et al.  New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. , 2007, Hematology/oncology clinics of North America.

[6]  G. Follows,et al.  Molecular genetic analysis of haematological malignancies II: mature lymphoid neoplasms , 2007, International journal of laboratory hematology.

[7]  N. Agnantis,et al.  Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas. , 2007, Anticancer research.

[8]  M. Carroll,et al.  p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors. , 2007, Blood.

[9]  T. Dyke.  p53 and tumor suppression. , 2007 .

[10]  G. Taylor.  Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma , 2006, Journal of Clinical Pathology.

[11]  H. Algood,et al.  Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses , 2006, Clinical Microbiology Reviews.

[12]  J. Dreiher,et al.  Non-Hodgkin Lymphoma and Pesticide Exposure: 25 Years of Research , 2006, Acta Haematologica.

[13]  K. Aozasa,et al.  Epidemiology and Pathologic Features of Hodgkin Lymphoma , 2006, International journal of hematology.

[14]  M. Seto,et al.  Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein , 2006, Leukemia.

[15]  J. Andersson.  Epstein-Barr virus and Hodgkin's lymphoma. , 2006, Herpes : the journal of the IHMF.

[16]  M. Gandhi.  Epstein–Barr virus-associated lymphomas , 2006, Expert review of anti-infective therapy.

[17]  A. Grulich,et al.  The epidemiology of non‐Hodgkin lymphoma , 2005, Pathology.

[18]  L. Campbell.  Cytogenetics of lymphomas , 2005, Pathology.

[19]  H. Iland,et al.  Molecular biology of lymphoma in the microarray era , 2005, Pathology.

[20]  D. Arber,et al.  Bone Marrow Biopsy Involvement by Non-Hodgkin's Lymphoma: Frequency of Lymphoma Types, Patterns, Blood Involvement, and Discordance With Other Sites in 450 Specimens , 2005, The American journal of surgical pathology.

[21]  R. Khanna,et al.  Viruses and lymphoma , 2005, Pathology.

[22]  M. Shuh,et al.  The human T‐cell leukemia virus type 1 (HTLV‐1): New insights into the clinical aspects and molecular pathogenesis of adult t‐cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV‐associated myelopathy (TSP/HAM) , 2005, Microscopy research and technique.

[23]  V. Diehl,et al.  Molecular pathogenesis of Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Chan,et al.  Helicobacter pylori and Gastric Malignancy , 2005, Helicobacter.

[25]  R. Felberbaum.  The molecular mechanisms of classic Hodgkin's lymphoma. , 2005, The Yale journal of biology and medicine.

[26]  J. Kobarg,et al.  Detection and Possible Prognostic Relevance of p53 Gene Mutations in Diffuse Large B-cell Lymphoma. An Analysis of 51 Cases and Review of the Literature , 2004, Leukemia & lymphoma.

[27]  A. Bagg.  Molecular diagnosis in lymphoma , 2004, Current oncology reports.

[28]  J. Sparano.  Human immunodeficiency virus associated lymphoma , 2003, Current opinion in oncology.

[29]  W. Wilson,et al.  Gene expression profiling of lymphomas , 2001, Current oncology reports.

[30]  S. Ansell,et al.  Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. , 1999, The American journal of surgical pathology.

[31]  W Hiddemann,et al.  Lymphoma classification--the gap between biology and clinical management is closing. , 1996, Blood.

[32]  K. Hübner,et al.  Histopathological classification of Hodgkin's lymphomas. Results from the reference pathology of the German Hodgkin Trial. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  Karin Ekstrom-Smedby,et al.  Epidemiology and etiology of non-Hodgkin lymphoma – a review , 2006 .

[34]  E. Cesarman,et al.  Pathogenesis of viral lymphomas. , 2006, Cancer treatment and research.

[35]  D. de Jong,et al.  Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus. , 2005, Blood cells, molecules & diseases.

[36]  H. Mobley,et al.  Pathogenesis of Helicobacter pylori infection. , 2000, Current opinion in gastroenterology.

[37]  James Olen Armitage,et al.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. , 1997, Blood.

[38]  Levin Eg,et al.  Cytogenetics of non-Hodgkin's lymphoma. , 1990 .

[39]  B. Schnitzer.  Classification of lymphomas. , 1978, CRC critical reviews in clinical laboratory sciences.